Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/30/2000WO2000042201A3 Human peptidases
11/30/2000WO2000042188A3 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
11/30/2000WO2000042178A3 Antagonist blockade of crf2 receptors for the treatment of psy chiatric disorders and the use of chimeric antisense oligonucleotides in in vivo cns studies of gene function
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000042072A3 Polypeptide variants with altered effector function
11/30/2000WO2000041549A3 Binary probe and clamp composition and methods for target hybridization detection
11/30/2000WO2000041509A3 Polypeptides having acid phosphatase activity and nucleic acids encoding same
11/30/2000WO2000040757A3 Method of identifying nucleic acids
11/30/2000WO2000040695A3 Sequence-determined dna fragments and corresponding polypeptides encoded thereby
11/30/2000WO2000040694A3 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
11/30/2000WO2000040606A3 Modulation of hiv replication using sam68
11/30/2000WO2000039337A9 Methods for robust discrimination of profiles
11/30/2000WO2000036121A3 Plant protein phosphatases
11/30/2000WO2000034481A3 DRUG TARGETS IN $i(CANDIDA ALBICANS)
11/30/2000WO2000032777A3 Scorpion toxins
11/30/2000WO2000032772A9 Erythropoietic compounds
11/30/2000WO2000031254A3 Apoptosis-inducing factor
11/30/2000WO2000029846A3 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000028019A3 Antisense oligomer
11/30/2000WO2000027340A9 USE OF t-RNA AND FRAGMENTS FOR INHIBITING ANGIOGENESIS AND COMPOSITIONS THEREOF
11/30/2000WO2000026380A9 Rotavirus subunit vaccine
11/30/2000WO2000025725A3 Functional antagonists of hedgehog activity
11/30/2000WO2000024895A3 Method and model for hair pigmentation
11/30/2000WO2000024415A9 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
11/30/2000WO2000022136A3 Recombinant e1a deleted adenoviral vectors
11/30/2000WO2000022100A3 Arthropod protein disulfide isomerases
11/30/2000WO2000018918A3 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/30/2000WO2000012704A3 Enhanced functional expression of g protein-coupled receptors
11/30/2000WO2000009658A8 Gene regulating circadian clock function and photoperiodism
11/30/2000EP1144624A3 Human and mouse trek-1 potassium channel protein and their use
11/30/2000DE19924606A1 Ligand-Anker-Konjugate The ligand-anchor conjugates
11/30/2000DE19924365A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren und für das accDA Gen codierende Nukleotidsequenzen A process for the fermentative preparation of L-amino acids, and nucleotide sequences coding for the accDA gene
11/30/2000DE19924364A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien A process for the fermentative preparation of L-amino acids using coryneform bacteria
11/30/2000DE19924342A1 Genetisch modifizierte Pflanzenzellen und Pflanzen mit erhöhter Aktivität eines Amylosucraseproteins und eines Verzweigungsenzyms Genetically modified plant cells and plants with an increased activity of an amylosucrase and a branching enzyme
11/30/2000DE19924199A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/30/2000DE19923966A1 Erkennungssystem zur Auftrennung von Probenbestandteilen, seine Herstellung und Verwendung Detection system for the separation of sample components, its preparation and use
11/30/2000DE19856064C2 Universelles Verfahren zur Isolierung von DNA aus beliebigen Ausgangsmaterialien Universal method for the isolation of DNA from any starting materials
11/30/2000DE10014575A1 Identifying organisms by comparative genetic analysis, useful e.g. in foods and forensic testing, comprises genotyping regions of highly conserved genes
11/30/2000CA2838395A1 Combination neisserial compositions
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2375180A1 Methods and system for amplitude normalization and selection of data peaks
11/30/2000CA2375032A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000CA2374941A1 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000CA2374918A1 Identification of novel mechanisms of drug resistance
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374608A1 Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid
11/30/2000CA2374550A1 Antigenic neisserial peptides
11/30/2000CA2374532A1 Recombinant bacterial phytases and uses thereof
11/30/2000CA2374531A1 Diagnostics and therapeutics for restenosis
11/30/2000CA2374524A1 Recombinant hosts suitable for simultaneous saccharification and fermentation
11/30/2000CA2374520A1 Secreted alpha-helical protein - 32
11/30/2000CA2374517A1 Inducible packaging cell lines for lentivirus vectors
11/30/2000CA2374515A1 Compositions and methods for labeling of nucleic acid molecules
11/30/2000CA2374507A1 Assay for the detection of paclitaxel resistant cells in human tumors
11/30/2000CA2374499A1 Antisense to c-myc for treatment of polycystic kidney disease
11/30/2000CA2374497A1 Method for generating split, non-transferable genes that are able to express an active protein product
11/30/2000CA2374494A1 Reverse transcription activity from bacillus stearothermophilus dna polymerase in the presence of magnesium
11/30/2000CA2374476A1 Interaction-activated proteins
11/30/2000CA2374462A1 Method for disrupting genes using tobacco retrotransposon
11/30/2000CA2374440A1 Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method
11/30/2000CA2374438A1 Detection system for studying molecular interactions and its preparationand use
11/30/2000CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000CA2374421A1 High specificity hairpin antisense oligonucleotides
11/30/2000CA2374416A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses
11/30/2000CA2374413A1 Human oxidoreductase proteins
11/30/2000CA2374380A1 Novel gene controlling abscisic acid synthesis
11/30/2000CA2374379A1 Novel gene controlling ethylene synthesis
11/30/2000CA2374375A1 Promoter having specific activity to pistil tissue and use of the same
11/30/2000CA2374364A1 Polypeptides and polynucleotides from moraxella catarrhalis
11/30/2000CA2374354A1 Immunogenic peptides derived from mage and the use thereof
11/30/2000CA2374341A1 Novel polypeptide
11/30/2000CA2374273A1 Liver function controlling agents
11/30/2000CA2374070A1 Tagged epitope protein transposable element
11/30/2000CA2374050A1 Vascular endothelial growth factor dimers
11/30/2000CA2374021A1 Methods for regulating protein conformation using molecular chaperones
11/30/2000CA2374019A1 Models of prion disease
11/30/2000CA2373822A1 Vascular endothelial growth factor variants
11/30/2000CA2373751A1 Isoflavonoid methylation enzyme
11/30/2000CA2373748A1 Use of chimeric mutational vectors to change endogenous nucleotide sequences in solid tissues
11/30/2000CA2373747A1 Fluorescence polarization assays involving polyions
11/30/2000CA2373744A1 A polynucleotide motor, a motor system, their preparation and uses
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373588A1 Gene therapy of pulmonary disease
11/30/2000CA2373372A1 Novel phytochelatin synthases and uses therefor
11/30/2000CA2373285A1 Diagnosis and treatment of atherosclerosis and coronary heart disease
11/30/2000CA2373236A1 Combination neisserial compositions
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2371828A1 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000CA2371659A1 Method for enhancing cellulose and modifying lignin biosynthesis in plants
11/30/2000CA2371500A1 Expression products of genes involved in diseases related to cholesterol metabolism
11/30/2000CA2370699A1 Refolding method of thrombin
11/30/2000CA2370332A1 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants
11/30/2000CA2366408A1 Inhibition of histone deacetylase
11/29/2000EP1055736A1 Method for dna sequencing
11/29/2000EP1055731A1 DNA which encodes trehalase and uses thereof
11/29/2000EP1055730A1 Process for the fermentative production of L-amino acids employing coryneform bacteria
11/29/2000EP1055729A1 Transgenic plants exhibiting an altered flowering time
11/29/2000EP1055727A2 Cloning of an N-methyltransferase involved in caffeine biosynthesis
11/29/2000EP1055726A1 Candida boidinii dihydroxyacetone synthase promoter
1 ... 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 3162 3163 3164 3165 3166 3167 3168 ... 4023